Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial. (2021)

First Author: Ejo M

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.21.0212

PubMed Identifier: 34615581

Publication URI: http://europepmc.org/abstract/MED/34615581

Type: Journal Article/Review

Volume: 25

Parent Publication: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Issue: 10

ISSN: 1027-3719